PHILIP ANDREWS: Open Payments
NPI 1164501490 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,444 in 163 payments from 21 companies in 2025. Trend: 2023 $3,063 · 2024 $3,140 · 2025 $5,444
Food & beverage: $4,319Consulting: $1,125
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $1,555 |
| Regeneron Healthcare Solutions, Inc. | 12 | $728 |
| GENZYME CORPORATION | 12 | $570 |
| UCB, Inc. | 13 | $421 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $331 |
| Lilly USA, LLC | 13 | $293 |
| Novartis Pharmaceuticals Corporation | 24 | $248 |
| LEO Pharma Inc. | 13 | $190 |
| Organon LLC | 3 | $163 |
| Galderma Laboratories, L.P. | 13 | $158 |
Products named: TREMFYA, DUPIXENT, Bimzelx, ILUMYA, COSENTYX, LIBTAYO, EBGLYSS, VTAMA.
Industry payments across TN — which companies pay providers there.
